Imagine... a few weeks after the birth of your child you realize they aren’t meeting critical developmental milestones and after months of doctor’s appointments you are told your baby has a rare neurological disease that would impact how they would live their lives.
This is the reality of parents whose children have Spinal Muscular Atrophy (SMA) and it’s the reason why we at Novartis Gene Therapies are laser focused on bringing hope and possibility to those devastated by rare genetic diseases.
We use cutting-edge technology to turn promising gene therapies into proven treatments beginning with SMA but also focusing on Rett Syndrome and Friedreich’s Ataxia.
Imagine the lives you could transform by joining the Novartis Gene Therapies team.
To view our latest job openings and apply, please see below.
Since Novartis Gene Therapies (formerly AveXis) was acquired in 2018, we have been strategically aligning to move towards One Novartis. This integration is actively underway and roles for Gene Therapies can be found under both the Novartis Career page, as well as, the Gene Therapies Career page.